Lantiseptic Dry Skin Therapy
FDA Label NDC 61924-710

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Dermarite Industries Llc for the product Lantiseptic Dry Skin Therapy (NDC 61924-710). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, directions, other information, inactive ingredients, questions or comments?, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Active Ingredient

Lanolin USP 30%

Purpose

Skin Protectant

Uses

  • Temporarily protects minor cuts, scrapes, and burns
  • Helps prevent and temporarily protects chafed, chapped, or cracked skin.

Warnings

• For external use only. • Avoid contact with eyes. •In case of contact, flush thoroughly with water.

Do not use on

  • deep or puncture wounds
  • animal bites
  • serious burns

    • Stop use and ask a doctor if

    • conditions worsen
    • symptoms last more than 7 days or clear up and occur again within a few days.

      • Keep our of reach of children

      In case of accidental ingestion contact a physician or Poison Control Center right away.

Directions

Apply liberally to affected area as needed or as directed by a physician.

Other Information

  • Store at room temperature (59-86°F)
  • You may report a serious adverse event to DermaRite Industries, PO Box 7209, North Bergen, NJ07047

Inactive Ingredients

Water, Mineral Oil, Petrolatum, Cera Alba, Sodium Borate, DMDM Hydantoin, Sorbitan Sesquioleate, Lanolin Alcohol, Disodium EDTA

Questions Or Comments?

Call 1-800-337-6296 Mon-Fri 9AM-5PM EST.

* Please review the disclaimer below.